Importance of Cadherins Methylation in Ovarian Cancer: a Next Generation Sequencing Approach

. 2019 Oct ; 25 (4) : 1457-1465. [epub] 20181027

Jazyk angličtina Země Švýcarsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid30368729

Grantová podpora
UHHK, 00179906 Ministerstvo Zdravotnictví Ceské Republiky
BBMRI, LM2015089 Ministerstvo Školství, Mládeže a Tělovýchovy

Odkazy

PubMed 30368729
DOI 10.1007/s12253-018-0500-y
PII: 10.1007/s12253-018-0500-y
Knihovny.cz E-zdroje

Epigenetic aberrations are well known to play an important role in carcinogenesis, and also have a great potential to serve as biomarkers in many types of cancers, including ovarian cancer in which sensitive and specific biomarkers and detection methods are critically needed. The aim of this study was to investigate methylation of cadherin genes CDH10, CDH13 and CDH18 in ovarian cancer tissue by comparison with control tissue. The study group consisted of 38 patients with ovarian cancer and 25 control patients. For detection of epigenetic events we used next generation sequencing, the most important data were confirmed using high-resolution melting analysis and real-time PCR. We observed significantly higher methylation in CDH13, sporadic methylation in CDH10 and loss of methylation in CDH18 in the ovarian cancer group compared with the control group. These observations suggest that changes in methylation of cadherin genes may be one of the major mechanisms associated with ovarian cancer progression. In addition, because of the high frequency of methylation of the CDH13 gene in the early stages of ovarian cancer, the analyzed CpG sites might be good targets for next study of potential ovarian cancer screening biomarkers.

Zobrazit více v PubMed

Mol Med Rep. 2014 Jul;10(1):3-9 PubMed

Asian Pac J Cancer Prev. 2014;15(15):6397-403 PubMed

Clin Cancer Res. 2002 Nov;8(11):3324-31 PubMed

Histopathology. 2010 Sep;57(3):363-70 PubMed

Pathol Oncol Res. 2015 Sep;21(4):921-7 PubMed

Gynecol Oncol. 2008 Apr;109(1):129-39 PubMed

Cell Tissue Res. 2014 Mar;355(3):523-7 PubMed

Front Mol Biosci. 2015 Apr 22;2:13 PubMed

Mol Cancer. 2012 Aug 08;11:53 PubMed

Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a003129 PubMed

Oncol Lett. 2015 Aug;10(2):647-652 PubMed

Gynecol Oncol. 2008 Nov;111(2):320-9 PubMed

Am J Surg Pathol. 2010 Mar;34(3):433-43 PubMed

BMC Syst Biol. 2014 Dec 31;8:1338 PubMed

J Clin Diagn Res. 2015 May;9(5):ZE05-7 PubMed

J Dent Res. 2007 Jun;86(6):544-9 PubMed

Folia Biol (Praha). 2012;58(6):246-50 PubMed

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Dec;157(4):298-303 PubMed

Genes Chromosomes Cancer. 2010 Sep;49(9):775-90 PubMed

Pathol Oncol Res. 2015 Jan;21(1):181-5 PubMed

Eur J Cancer. 2013 Apr;49(6):1374-403 PubMed

Med Oncol. 2014 Aug;31(8):100 PubMed

J Cell Sci. 2001 Feb;114(Pt 4):629-41 PubMed

Exp Ther Med. 2012 Dec;4(6):1092-1096 PubMed

Mod Pathol. 2008 Feb;21(2):85-95 PubMed

Sci Rep. 2015 Oct 27;5:14237 PubMed

Int J Mol Sci. 2017 Feb 22;18(2): PubMed

Int J Cancer. 2011 Oct 1;129(7):1635-42 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...